Cholangiocarcinoma diagnosis and treatment

[1] Shin DW, Moon SH, Kim JH. Diagnosis of cholangiocarcinoma. Diagnostics (Basel). 2023; 13:233. ShinDW MoonSH KimJH Diagnosis of cholangiocarcinoma Diagnostics (Basel) 2023 13 233 Search in Google Scholar

[2] Kendall T, Verheij J, Gaudio E, Evert M, Guido M, Goeppert B, Carpino G. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 2019; 39(Suppl 1):7–18. KendallT VerheijJ GaudioE EvertM GuidoM GoeppertB CarpinoG Anatomical, histomorphological and molecular classification of cholangiocarcinoma Liver Int 2019 39 Suppl 1 7 18 Search in Google Scholar

[3] Lalani T, Couto CA, Rosen MP, Baker ME, Blake MA, Cash BD, et al. ACR appropriateness criteria jaundice. J Am Coll Radiol. 2013; 10:402–9. LalaniT CoutoCA RosenMP BakerME BlakeMA CashBD ACR appropriateness criteria jaundice J Am Coll Radiol 2013 10 402 9 Search in Google Scholar

[4] Shen WF, Zhong W, Xu F, Kan T, Geng L, Xie F, et al. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol. 2009; 15:5976–82. ShenWF ZhongW XuF KanT GengL XieF Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma World J Gastroenterol 2009 15 5976 82 Search in Google Scholar

[5] Pabst KM, Trajkovic-Arsic M, Cheung PFY, Ballke S, Steiger K, Bartel T, et al. Superior tumor detection for ⁶⁸Ga-FAPI-46 versus ¹⁸F-FDG PET/CT and conventional CT in patients with cholangiocarcinoma. J Nucl Med. 2023; 64:1049–55. PabstKM Trajkovic-ArsicM CheungPFY BallkeS SteigerK BartelT Superior tumor detection for ⁶⁸Ga-FAPI-46 versus ¹⁸F-FDG PET/CT and conventional CT in patients with cholangiocarcinoma J Nucl Med 2023 64 1049 55 Search in Google Scholar

[6] Labib PL, Goodchild G, Pereira SP. Molecular Pathogenesis of cholangiocarcinoma. BMC Cancer. 2019; 19:185. doi: 10.1186/s12885-019-5391-0 LabibPL GoodchildG PereiraSP Molecular Pathogenesis of cholangiocarcinoma BMC Cancer 2019 19 185 10.1186/s12885-019-5391-0 Open DOISearch in Google Scholar

[7] Lu S, Li J. Treatment of cholangiocarcinoma by pGCsiRNA-vascular endothelial growth factor in vivo. Asian Biomed (Res Rev News). 2024; 18:61–8. LuS LiJ Treatment of cholangiocarcinoma by pGCsiRNA-vascular endothelial growth factor in vivo Asian Biomed (Res Rev News) 2024 18 61 8 Search in Google Scholar

[8] Elvevi A, Laffusa A, Scaravaglio M, Rossi RE, Longarini R, Stagno AM, et al. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Ann Hepatol. 2022; 27:100737. doi: 10.1016/j.aohep.2022.100737 ElveviA LaffusaA ScaravaglioM RossiRE LongariniR StagnoAM Clinical treatment of cholangiocarcinoma: an updated comprehensive review Ann Hepatol 2022 27 100737 10.1016/j.aohep.2022.100737 Open DOISearch in Google Scholar